PRESS RELEASE
28 May 2025

TSCA Reform — Nine Years Later June 25, 2025, 8:30 A.m. – 4:30 P.m. (EDT)

BC
Bergeson & Campbell

Contributor

Bergeson & Campbell, P.C. is a Washington D.C. law firm focusing on chemical product approval and regulation, product defense, and associated business issues. The Acta Group, B&C's scientific and regulatory consulting affiliate provides strategic, comprehensive support for global chemical registration, regulation, and sustained compliance. Together, we help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products globally.
Bergeson & Campbell, P.C. (B&C®), the Environmental Law Institute (ELI), and the George Washington University Milken Institute School of Public Health are pleased to present “TSCA Reform — Nine Years Later”...
United States

For complimentary registration, visit the ELI registration page:
https://www.eli.org/events/tsca-reform-nine-years-later

Bergeson & Campbell, P.C. (B&C®), the Environmental Law Institute (ELI), and the George Washington University Milken Institute School of Public Health are pleased to present “TSCA Reform — Nine Years Later” on June 25, 2025. This complimentary virtual conference marks the ninth Toxic Substances Control Act (TSCA) Annual Conference. As with our previous TSCA events, a stellar faculty of speakers from government, non-governmental organizations, industry, and academia will convene to inform, analyze, discuss, and debate the most pressing issues related to TSCA with regulatory practitioners and other stakeholder attendees. With a new Trump Administration and the relentless pace of regulatory developments related to implementation of the Frank R. Lautenberg Chemical Safety for the 21st Century Act (Lautenberg), there are many issues to consider and problems to solve.

Register Today

Full Agenda (subject to change):

All times Eastern.

June 25, 2025

8:30 a.m. – 8:35 a.m.
Welcome

Madison Calhoun, Senior Manager, Educational Programs, Environmental Law Institute

8:35 a.m. – 9:00 a.m.
Setting the Stage — An Overview of Today’s Program

Nine years after enactment of Lautenberg, who would have guessed its implementation and the state of chemical safety remain the subject of considerable uncertainty and legal debate? This discussion will set the stage for a day of stimulating but respectful debate on the state of TSCA play and the big issues that remain unresolved.

Lynn L. Bergeson, Managing Partner, Bergeson & Campbell, P.C.

Robert M. Sussman, Principal, Sussman & Associates

9:00 a.m. – 10:00 a.m.
Panel 1: Risk Management

All five final risk management rules are being litigated, and the new Administration’s approach to risk management is expected to change. This panel discussion will address the common elements of these five final rules, cross-cutting and key legal and policy issues in dispute, offer a litigation update and timetable for judicial decisions, speculate on what the U.S. Environmental Protection Agency (EPA) could do differently in future rules, and discuss the Workplace Chemical Protection Program’s (WCPP) alignment with Occupational Health and Safety Administration (OSHA) requirements.

Robert M. Sussman, Principal, Sussman & Associates, Moderator

Keith Bradley, Partner, Squire Patton Boggs

Ryan J. Carra, Ph.D., Principal, Beveridge & Diamond, P.C.

Jonathan Kalmuss-Katz, Staff Attorney, Earthjustice

Randy S. Rabinowitz, Executive Director, OSH Law Project, LLC

10:00 a.m. – 11:00 a.m.
Panel 2: Risk Evaluation

EPA is revisiting the foundational underpinnings of the 2024 Risk Evaluation Procedural Framework rule, and there is considerable uncertainty on how EPA will approach upcoming risk evaluations. This panel will explore the interplay between the D.C. Circuit case and risk management litigation, review recent draft formaldehyde and butadiene risk evaluations, discuss key cross-cutting issues, identify key science issues, and discuss the prioritization and scoping processes.

Mark N. Duvall, Principal, Beveridge & Diamond, P.C., Moderator

Rashmi Joglekar, Ph.D., Associate Director of Science & Policy, University of California San Francisco, Program on Reproductive Health and the Environment

M. Andrew Maier, Ph.D., Principal Health Scientist, Integral Consulting Inc.

Tosh Sagar, Senior Attorney, Earthjustice

Karyn M. Schmidt, Partner, Squire Patton Boggs

11:00 a.m. – 11:15 a.m. Break

11:15 a.m. – 12:15 p.m.
Panel 3: New Chemical Review

New chemical review remains a particularly hot topic, and EPA has implemented many changes and devoted considerable energy to addressing concerns and accelerating the process. This panel will provide an update on metrics and approaches, discuss premanufacture notice (PMN) completeness/supplemental submissions/rework, the approach to Significant New Use Rules (SNUR), confidential business information (CBI) issues, and adequacy of resources.

Greg Schweer, Principal, Environmental Consulting, LLC, Moderator

Kyla Bennett, Director of Science Policy; Northeast & Mid-Atlantic Director, Public Employees for Environmental Responsibility

Lawrence E. Culleen, Partner, Arnold & Porter Kaye Scholer LLP

Maria J. Doa, Ph.D., Senior Director, Chemical Policy, Environmental Defense Fund

Richard E. Engler, Ph.D., Director of Chemistry, Bergeson & Campbell, P.C.

12:15 p.m. – 1:15 p.m.
Lunch and Keynote Address: TSCA Implementation — An EPA Perspective

Nancy B. Beck, Ph.D., Principal Deputy Assistant Administrator, EPA Office of Chemical Safety and Pollution Prevention

1:15 p.m. – 2:15 p.m.
Panel 4: Plastics Production, Use, and Recycling: Key TSCA Considerations

Plastic production use and disposal is a global issue garnering significant interest. This panel will explore key TSCA issues including platform chemicals and precursors, additives, and intermediates, public health concerns, microplastics, the scope of TSCA risk evaluations, advanced recycling, PMN/SNUR requirements for pyrolysis oils, and more.

Martha E. Marrapese, Partner, Wiley Rein LLP, Moderator

Eve C. Gartner, Director of Crosscutting Toxics Strategies, Earthjustice

Jeff Gold, Founder and CTO, Nexus Circular

Jessie M. Kneeland, Ph.D., Principal Scientist, Gradient® Corporation

Renee Sharp, Director, Plastics and Petrochemical Advocacy, Environmental Health, Natural Resources Defense Council

2:15 p.m. – 2:30 p.m. Break

2:30 p.m. – 3:15 p.m.
Panel 5: Chronic Disease: What Role Chemicals Play

This point and counterpoint discussion will address the role chemicals play in chronic disease.

Lynn L. Bergeson, Managing Partner, Bergeson & Campbell, P.C., Moderator

Linda S. Birnbaum, Ph.D., D.A.B.T., A.T.S., Scientist Emeritus and Former Director, National Institute of Environmental Health Sciences and National Toxicology Program; Scholar in Residence, Nicholas School of the Environment, Duke University

Paolo Boffetta, MD, MPH, Stony Brook Cancer Center

3:15 p.m. – 4:15 p.m.
Panel 6: TSCA Reform Redux: Change Beyond Fee Reauthorization?

The TSCA community is buzzing with the prospect of TSCA legislative reform occasioned by the 2026 lapsing of TSCA’s fee authorization. Stakeholders are divided on whether we need to reopen TSCA and, if so, whether fine tuning or extensive revisions are needed. This panel will consider how well the law is working, what changes are under consideration, and what happens if nothing happens.

Daniel Savery, Senior Legislative Representative, Earthjustice, Moderator

Liz Hitchcock, Director, Federal Policy Program, Toxic-Free Future

Daniel Rosenberg, Director, Federal Toxics Policy, Environmental Health, Natural Resources Defense Council

Kimberly Wise White, Ph.D., Vice President, Regulatory and Scientific Affairs, American Chemistry Council

4:15 p.m. – 4:30 p.m.
Concluding Remarks and Adjournment

Jordan Diamond, President, Environmental Law Institute

For complimentary registration, visit the ELI registration page: https://www.eli.org/events/tsca-reform-nine-years-later

Contributor

Bergeson & Campbell, P.C. is a Washington D.C. law firm focusing on chemical product approval and regulation, product defense, and associated business issues. The Acta Group, B&C's scientific and regulatory consulting affiliate provides strategic, comprehensive support for global chemical registration, regulation, and sustained compliance. Together, we help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products globally.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More